logo

CLSD

Clearside Biomedical
--
--(--)
Market Open: --
--
--(--)
Post-Market: --

CLSD fundamentals

Clearside Biomedical (CLSD) expects to report earnings on Aug 11, 2025, with estimated revenue of 498.43K (YoY +453.81%), and EPS at -0.1 (YoY 0.00%).
Revenue estimate / YoY
498.43K
+453.81%
EPS estimate / YoY
-0.1
0.00%
Report date
Aug 11, 2025
EPS
Revenue

Revenue & Expenses

CLSD has released its 2025 Q1 earnings report, with revenue of 2.33M, reflecting a YoY change of 913.04%, and net profit of -8.22M, showing a YoY change of 30.09%. The Sankey diagram below clearly presents CLSD's revenue sources and cost distribution.

Key Indicators

Clearside Biomedical (CLSD) key financial stats and ratios, covering profitability, financial health, and leverage.
Clearside Biomedical (CLSD)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Clearside Biomedical (CLSD)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Clearside Biomedical (CLSD)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Clearside Biomedical (CLSD) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Clearside Biomedical (CLSD) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield